Biogen Inc.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spina…
Drug Manufacturers - General
US, Cambridge [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Biogen Inc.'s gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2014 | 7.8600 | 11.540 | 6,932 | 8,977 | 1,862 | 2,664 | 2,807 | 4,224 | 2,490 | 3,606 | 1,712 | 2,041 |
| 2015 | 12.4200 | 16.510 | 9,703 | 10,630 | 2,934 | 3,280 | 4,350 | 4,996 | 3,916 | 4,514 | 2,232 | 1,966 |
| 2016 | 15.3800 | 20.168 | 10,763 | 11,515 | 3,547 | 3,455 | 5,521 | 5,493 | 5,014 | 4,805 | 2,113 | 1,826 |
| 2017 | 16.9600 | 21.994 | 11,448 | 12,051 | 3,702 | 2,246 | 6,541 | 5,905 | 5,653 | 5,009 | 1,947 | 1,826 |
| 2018 | 11.9400 | 25.918 | 12,273 | 13,326 | 2,539 | 4,142 | 6,526 | 6,617 | 5,527 | 5,511 | 1,935 | 1,970 |
| 2019 | 21.6200 | 33.243 | 13,452 | 14,243 | 4,430 | 5,318 | 6,860 | 7,165 | 6,000 | 6,330 | 2,106 | 2,152 |
| 2020 | 31.4700 | 33.790 | 14,377 | 13,380 | 5,888 | 3,268 | 7,518 | 4,650 | 7,035 | 3,542 | 2,374 | 2,237 |
| 2021 | 24.8600 | 19.192 | 13,444 | 10,872 | 4,000 | 1,366 | 4,807 | 2,182 | 4,446 | 2,531 | 2,504 | 2,373 |
| 2022 | 10.4400 | 17.108 | 10,981 | 10,072 | 1,556 | 1,820 | 3,656 | 3,377 | 2,808 | 2,738 | 2,674 | 2,619 |
| 2023 | 20.9700 | 14.995 | 10,173 | 9,928 | 3,046 | 1,161 | 2,686 | 3,889 | 2,901 | 3,119 | 2,403 | 2,948 |
| 2024 | 8.0200 | 16.410 | 9,835 | 9,632 | 1,161 | 2,389 | 2,598 | 3,355 | 1,831 | 2,947 | 2,549 | 2,100 |
| 2025 | - | 16.926 | - | 9,543 | - | 2,084 | - | 3,324 | - | 2,919 | - | 2,081 |
| 2026 | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F121/td> | - | 2.F121 | - | 2.F121 |
| 2027 | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F131/td> | - | 1.F131 | - | 1.F131 |
| 2028 | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F141/td> | - | 0.F141 | - | 0.F141 |